Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytidine triphosphate synthase is a key enzyme (EC 6.3.4.2) in the de novo synthesis of pyrimidine nucleotides. It catalyzes the ATP- and glutamine-dependent amination of uridine triphosphate (UTP) to form cytidine triphosphate (CTP), which is essential for DNA, RNA, and phospholipid synthesis. CTPS is the rate-limiting step in cytosine nucleotide biosynthesis and is regulated by feedback from its product. The enzyme can polymerize into filaments ("cytoophidia") in cells, with regulatory implications. Increased CTPS activity has been observed in various cancers, and mutations confer drug resistance in some cell models. CTPS is a validated but challenging therapeutic target due to its central metabolic role and toxicity risks if inhibited in proliferating normal tissues.
Competitive inhibition of CTP synthase activity; Depletion of cytidine triphosphate pool, inhibiting DNA/RNA synthesis; Disruption of nucleotide balance, blocking cell proliferation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytidine triphosphate synthase (CTPS).